Treatment with olanzapine plus samidorphan, an opioid antagonist, resulted in 37% lower weight gain than treatment with olanzapine plus placebo in patients with schizophrenia, according to data from a phase 2 study.
In previous preclinical and phase 1 clinical studies, samidorphan has been shown to mitigate weight gain associated with olanzapine use, William F. Martin, PhD, of Alkermes, Inc., and colleagues wrote in American Journal of Psychiatry.
This activity is not supported by a commercial educational grant.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.